Matteo Brognoli (MD Solaris) and John Robert Durant (Director MIT Museum)
Bioreactor Solaris Jupiter at the MIT museum 2
Matteo Brognoli with Bioreactor Solaris Jupiter at the MIT museum
Italian Solaris shows bioreactor at the new MIT museum in Kendall, Cambridge.
The show is a part of Solaris’ program for the data on bioprocessing
— Matteo Brognoli, Managing Director of Solaris Biotech
CAMBRIDGE, MASSACHUSETTS, USA, October 3, 2022 /EINPresswire.com/ — Solaris Biotech is proud to announce that the MIT (Massachusetts Institute of Technology) shows a bioreactor loaned by Solaris in the new museum that has opened to the public on Oct. 2.
Solaris Biotech is a number one innovator and producer of bioreactors, fermenters and tangential circulate filtration programs that allow the know-how for use for quite a lot of functions in the pharmaceutical, biopharmaceutical and meals industries.
Matteo Brognoli, Managing Director of Solaris Biotech, says, “We at Solaris contemplate it a privilege to be a part of the new exhibition of the MIT museum, a world excellence in the area of science and know-how. Bioprocessing actually can clear up many issues that mankind is dealing with in the future and we testify our delight in being a part of a mission-based, academic effort of this measurement. Sometimes persons are afraid of cultivated cells and proteins, however they have no idea that bioprocessing is the base of vaccines, many medicines, cosmetics, feed, fertilizers, even meat, honey and fish. The new MIT museum with its mission to convey science near the public is a spot to be for those that foster innovation for a extra sustainable and wholesome world.”
Solaris, which grew to become a part of the Donaldson Group in November 2021, is cooperating with a number of universities in Italy and can help the Galileo Festival of Science in Padova on October 14, 2022. Matteo Brognoli will converse at a panel on cultivated proteins along with Justin Kolbek (Wild Type Foods), the nutritionist Lucilla Titta and the genetist Michele Morgante, professor at the University of Udine (Italy).
SOLARIS BIOTECH
Solaris Biotechnology, a Donaldson Group firm, was based in 2002 and is a frontrunner in creating biotechnology options for cGMP functions in the Food & Beverage and Biopharmaceutical sectors. It makes a speciality of the manufacture of fermenters, bioreactors, and tangential circulate (TFF) and depth filtration (FFF) programs. Top product growth and design groups allow Solaris to create options at all scales, from bench-top R&D programs to finish engineered options tailor-made to particular person buyer wants.
Solaris has its administrative and manufacturing headquarters in the province of Mantua. It has three gross sales and repair places of work in San Francisco Bay Area, California, Cambridge, Boston, and Kuala Lumpur, Malaysia, in addition to a community of native representatives in additional than 40 international locations round the world. Solaris assists its prospects step-by-step in the design and implementation of full course of vegetation, from feasibility research to start-up.
In November 2021, Solaris grew to become a part of the Donaldson Company based mostly in Bloomington, MN.
The firm exports bioreactors and fermenters worldwide and is amongst the leaders in the trade. Biotechnology is a rising area whose functions influence all elements of every day life, from prescribed drugs to cosmetics, from wines to agriculture.
Raffaello Porro
StudioRPR
+39 335 101 5456
e mail us right here
Visit us on social media:
LinkedIn
